| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 25.408 | 876.651 | 420.693 | 165.550 | 238.564 | 341.847 |
| Total Income - EUR | - | - | - | 0 | 25.408 | 876.681 | 420.957 | 165.581 | 238.587 | 345.108 |
| Total Expenses - EUR | - | - | - | 89 | 17.743 | 431.518 | 216.359 | 107.451 | 157.632 | 172.035 |
| Gross Profit/Loss - EUR | - | - | - | -89 | 7.665 | 445.163 | 204.598 | 58.130 | 80.954 | 173.073 |
| Net Profit/Loss - EUR | - | - | - | -89 | 7.411 | 437.640 | 201.161 | 56.870 | 79.185 | 164.335 |
| Employees | - | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Almed Biotehnix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 2.745 | 68.346 | 50.281 | 29.967 | 7.863 |
| Current Assets | - | - | - | 51 | 21.111 | 520.115 | 199.441 | 145.400 | 186.752 | 325.671 |
| Inventories | - | - | - | 0 | 0 | 1.041 | 12.562 | 17.608 | 15.353 | 20.150 |
| Receivables | - | - | - | 0 | 8.619 | 137.246 | 96.468 | 38.174 | 72.231 | 279.684 |
| Cash | - | - | - | 51 | 12.492 | 381.828 | 90.410 | 89.618 | 99.168 | 25.836 |
| Shareholders Funds | - | - | - | -46 | 7.366 | 437.731 | 201.258 | 56.967 | 135.980 | 197.181 |
| Social Capital | - | - | - | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | 97 | 13.816 | 85.736 | 67.100 | 139.606 | 81.565 | 137.051 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Almed Biotehnix S.r.l.